Sarcomas developed in patients with Lynch Syndrome are enriched in pleomorphic soft-tissue sarcomas and are sensitive to immunotherapy.
Saved in:
| Title: | Sarcomas developed in patients with Lynch Syndrome are enriched in pleomorphic soft-tissue sarcomas and are sensitive to immunotherapy. |
|---|---|
| Authors: | Poumeaud F; Department of Medical Oncology, Oncopole Claudius Regaud, Toulouse, France; Department of Digestive Medical Oncology, Toulouse University Hospital, Toulouse, France; Toulouse Cancer Research Centre, Toulouse, France., Valentin T; Department of Medical Oncology, Oncopole Claudius Regaud, Toulouse, France; Toulouse Cancer Research Centre, Toulouse, France., Fares N; Department of Digestive Medical Oncology, Toulouse University Hospital, Toulouse, France; Toulouse Cancer Research Centre, Toulouse, France., Segier B; Biostatistics & Health Date Science Unit, Oncopole Claudius Regaud IUCT-O, Toulouse, France., Watson S; Department of Medical Oncology, Institut Curie, Paris, France., Verret B; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France., Tlemsani C; Department of Medical Oncology, APHP, Paris, France., Penel N; Department of Medical Oncology, Centre Oscar Lambret, Lille, France., Lejeune S; Department of Oncogenetics, Lille University Hospital, Lille, France., Firmin N; Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France., Sabouret A; Department of Medical Oncology, Institut Curie, Paris, France., Thery JC; Department of Medical Oncology, Centre Henri Becquerel, Rouen, France., Bonvalot S; Biostatistics & Health Date Science Unit, Oncopole Claudius Regaud IUCT-O, Toulouse, France., Cottereau E; Department of Oncogenetics, Tours University Hospital, Tours, France., Cauchin E; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint-Herblain, France., Lancon A; Department of Oncogenetics, Centre Georges François Leclerc, Dijon, France., Nambot S; Department of Oncogenetics, Centre Georges François Leclerc, Dijon, France., Zattara H; Department of Oncogenetics, Marseille University Hospital, Marseille, France., Coudert M; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint-Herblain, France., Fourme E; Biostatistics & Health Date Science Unit, Oncopole Claudius Regaud IUCT-O, Toulouse, France., Nogues C; Department of Oncogenetics, Institut Paoli Calmettes, Marseille, France., Tougeron D; Department of Medical Oncology, Poitiers University Hospital, Poitiers, France., Prieur F; Department of Oncogenetics, Saint Etienne University Hospital, Saint Etienne, France., Collonge-Rame MA; Department of Oncogenetics, Besançon University Hospital, Besançon, France., Denis C; Department of Oncogenetics, Strasbourg University Hospital, Strasbourg, France., Laurent-Puig P; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France., Chieze-Valero S; Department of Oncogenetics, Niort Hospital Centre, Niort, France., Dreyfus H; Department of Medical Oncology, Institut Sainte Catherine, Avignon, France., Jaffrelot M; Department of Digestive Medical Oncology, Toulouse University Hospital, Toulouse, France; Department of Oncogenetics, Oncopole Claudius Regaud, Toulouse, France., Vande Perre P; Department of Oncogenetics, Oncopole Claudius Regaud, Toulouse, France., Rochaix P; Toulouse Cancer Research Centre, Toulouse, France; Department of Pathology, Toulouse University Hospital, Toulouse, France., Gomez-Mascard A; Toulouse Cancer Research Centre, Toulouse, France; Department of Pathology, Toulouse University Hospital, Toulouse, France., Rochefort P; Department of Oncogenetics, Centre Léon Bérard, Lyon, France; Groupe Génétique et Cancer, Unicancer, France., Campoy S; Department of Oncogenetics, Centre Léon Bérard, Lyon, France; Groupe Génétique et Cancer, Unicancer, France., Chibon F; Toulouse Cancer Research Centre, Toulouse, France; Department of Pathology, Toulouse University Hospital, Toulouse, France., Lasset C; Department of Oncogenetics, Centre Léon Bérard, Lyon, France; Groupe Génétique et Cancer, Unicancer, France., Selves J; Toulouse Cancer Research Centre, Toulouse, France; Department of Pathology, Toulouse University Hospital, Toulouse, France., Guimbaud R; Department of Digestive Medical Oncology, Toulouse University Hospital, Toulouse, France; Toulouse Cancer Research Centre, Toulouse, France; Department of Oncogenetics, Oncopole Claudius Regaud, Toulouse, France; Groupe Génétique et Cancer, Unicancer, France. Electronic address: guimbaud.r@chu-toulouse.fr. |
| Source: | European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Feb 05; Vol. 216, pp. 115196. Date of Electronic Publication: 2024 Dec 21. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39742560 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Sarcomas developed in patients with Lynch Syndrome are enriched in pleomorphic soft-tissue sarcomas and are sensitive to immunotherapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Poumeaud+F%22">Poumeaud F</searchLink>; Department of Medical Oncology, Oncopole Claudius Regaud, Toulouse, France; Department of Digestive Medical Oncology, Toulouse University Hospital, Toulouse, France; Toulouse Cancer Research Centre, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Valentin+T%22">Valentin T</searchLink>; Department of Medical Oncology, Oncopole Claudius Regaud, Toulouse, France; Toulouse Cancer Research Centre, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Fares+N%22">Fares N</searchLink>; Department of Digestive Medical Oncology, Toulouse University Hospital, Toulouse, France; Toulouse Cancer Research Centre, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Segier+B%22">Segier B</searchLink>; Biostatistics & Health Date Science Unit, Oncopole Claudius Regaud IUCT-O, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Watson+S%22">Watson S</searchLink>; Department of Medical Oncology, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Verret+B%22">Verret B</searchLink>; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Tlemsani+C%22">Tlemsani C</searchLink>; Department of Medical Oncology, APHP, Paris, France.<br /><searchLink fieldCode="AU" term="%22Penel+N%22">Penel N</searchLink>; Department of Medical Oncology, Centre Oscar Lambret, Lille, France.<br /><searchLink fieldCode="AU" term="%22Lejeune+S%22">Lejeune S</searchLink>; Department of Oncogenetics, Lille University Hospital, Lille, France.<br /><searchLink fieldCode="AU" term="%22Firmin+N%22">Firmin N</searchLink>; Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Sabouret+A%22">Sabouret A</searchLink>; Department of Medical Oncology, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Thery+JC%22">Thery JC</searchLink>; Department of Medical Oncology, Centre Henri Becquerel, Rouen, France.<br /><searchLink fieldCode="AU" term="%22Bonvalot+S%22">Bonvalot S</searchLink>; Biostatistics & Health Date Science Unit, Oncopole Claudius Regaud IUCT-O, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Cottereau+E%22">Cottereau E</searchLink>; Department of Oncogenetics, Tours University Hospital, Tours, France.<br /><searchLink fieldCode="AU" term="%22Cauchin+E%22">Cauchin E</searchLink>; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint-Herblain, France.<br /><searchLink fieldCode="AU" term="%22Lancon+A%22">Lancon A</searchLink>; Department of Oncogenetics, Centre Georges François Leclerc, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Nambot+S%22">Nambot S</searchLink>; Department of Oncogenetics, Centre Georges François Leclerc, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Zattara+H%22">Zattara H</searchLink>; Department of Oncogenetics, Marseille University Hospital, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Coudert+M%22">Coudert M</searchLink>; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint-Herblain, France.<br /><searchLink fieldCode="AU" term="%22Fourme+E%22">Fourme E</searchLink>; Biostatistics & Health Date Science Unit, Oncopole Claudius Regaud IUCT-O, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Nogues+C%22">Nogues C</searchLink>; Department of Oncogenetics, Institut Paoli Calmettes, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Tougeron+D%22">Tougeron D</searchLink>; Department of Medical Oncology, Poitiers University Hospital, Poitiers, France.<br /><searchLink fieldCode="AU" term="%22Prieur+F%22">Prieur F</searchLink>; Department of Oncogenetics, Saint Etienne University Hospital, Saint Etienne, France.<br /><searchLink fieldCode="AU" term="%22Collonge-Rame+MA%22">Collonge-Rame MA</searchLink>; Department of Oncogenetics, Besançon University Hospital, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Denis+C%22">Denis C</searchLink>; Department of Oncogenetics, Strasbourg University Hospital, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Laurent-Puig+P%22">Laurent-Puig P</searchLink>; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Chieze-Valero+S%22">Chieze-Valero S</searchLink>; Department of Oncogenetics, Niort Hospital Centre, Niort, France.<br /><searchLink fieldCode="AU" term="%22Dreyfus+H%22">Dreyfus H</searchLink>; Department of Medical Oncology, Institut Sainte Catherine, Avignon, France.<br /><searchLink fieldCode="AU" term="%22Jaffrelot+M%22">Jaffrelot M</searchLink>; Department of Digestive Medical Oncology, Toulouse University Hospital, Toulouse, France; Department of Oncogenetics, Oncopole Claudius Regaud, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Vande+Perre+P%22">Vande Perre P</searchLink>; Department of Oncogenetics, Oncopole Claudius Regaud, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Rochaix+P%22">Rochaix P</searchLink>; Toulouse Cancer Research Centre, Toulouse, France; Department of Pathology, Toulouse University Hospital, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Gomez-Mascard+A%22">Gomez-Mascard A</searchLink>; Toulouse Cancer Research Centre, Toulouse, France; Department of Pathology, Toulouse University Hospital, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Rochefort+P%22">Rochefort P</searchLink>; Department of Oncogenetics, Centre Léon Bérard, Lyon, France; Groupe Génétique et Cancer, Unicancer, France.<br /><searchLink fieldCode="AU" term="%22Campoy+S%22">Campoy S</searchLink>; Department of Oncogenetics, Centre Léon Bérard, Lyon, France; Groupe Génétique et Cancer, Unicancer, France.<br /><searchLink fieldCode="AU" term="%22Chibon+F%22">Chibon F</searchLink>; Toulouse Cancer Research Centre, Toulouse, France; Department of Pathology, Toulouse University Hospital, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Lasset+C%22">Lasset C</searchLink>; Department of Oncogenetics, Centre Léon Bérard, Lyon, France; Groupe Génétique et Cancer, Unicancer, France.<br /><searchLink fieldCode="AU" term="%22Selves+J%22">Selves J</searchLink>; Toulouse Cancer Research Centre, Toulouse, France; Department of Pathology, Toulouse University Hospital, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Guimbaud+R%22">Guimbaud R</searchLink>; Department of Digestive Medical Oncology, Toulouse University Hospital, Toulouse, France; Toulouse Cancer Research Centre, Toulouse, France; Department of Oncogenetics, Oncopole Claudius Regaud, Toulouse, France; Groupe Génétique et Cancer, Unicancer, France. Electronic address: guimbaud.r@chu-toulouse.fr. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2025 Feb 05; Vol. 216, pp. 115196. <i>Date of Electronic Publication: </i>2024 Dec 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39742560 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ejca.2024.115196 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 115196 Titles: – TitleFull: Sarcomas developed in patients with Lynch Syndrome are enriched in pleomorphic soft-tissue sarcomas and are sensitive to immunotherapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Poumeaud F – PersonEntity: Name: NameFull: Valentin T – PersonEntity: Name: NameFull: Fares N – PersonEntity: Name: NameFull: Segier B – PersonEntity: Name: NameFull: Watson S – PersonEntity: Name: NameFull: Verret B – PersonEntity: Name: NameFull: Tlemsani C – PersonEntity: Name: NameFull: Penel N – PersonEntity: Name: NameFull: Lejeune S – PersonEntity: Name: NameFull: Firmin N – PersonEntity: Name: NameFull: Sabouret A – PersonEntity: Name: NameFull: Thery JC – PersonEntity: Name: NameFull: Bonvalot S – PersonEntity: Name: NameFull: Cottereau E – PersonEntity: Name: NameFull: Cauchin E – PersonEntity: Name: NameFull: Lancon A – PersonEntity: Name: NameFull: Nambot S – PersonEntity: Name: NameFull: Zattara H – PersonEntity: Name: NameFull: Coudert M – PersonEntity: Name: NameFull: Fourme E – PersonEntity: Name: NameFull: Nogues C – PersonEntity: Name: NameFull: Tougeron D – PersonEntity: Name: NameFull: Prieur F – PersonEntity: Name: NameFull: Collonge-Rame MA – PersonEntity: Name: NameFull: Denis C – PersonEntity: Name: NameFull: Laurent-Puig P – PersonEntity: Name: NameFull: Chieze-Valero S – PersonEntity: Name: NameFull: Dreyfus H – PersonEntity: Name: NameFull: Jaffrelot M – PersonEntity: Name: NameFull: Vande Perre P – PersonEntity: Name: NameFull: Rochaix P – PersonEntity: Name: NameFull: Gomez-Mascard A – PersonEntity: Name: NameFull: Rochefort P – PersonEntity: Name: NameFull: Campoy S – PersonEntity: Name: NameFull: Chibon F – PersonEntity: Name: NameFull: Lasset C – PersonEntity: Name: NameFull: Selves J – PersonEntity: Name: NameFull: Guimbaud R IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 02 Text: 2025 Feb 05 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1879-0852 Numbering: – Type: volume Value: 216 Titles: – TitleFull: European journal of cancer (Oxford, England : 1990) Type: main |
| ResultId | 1 |